lifestyle.longislandreport.org

Author: F. Hoffman-La Roche AG

/C O R R E C T I O N — Roche/

March 24, 2026
Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets

March 24, 2026
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease

March 16, 2026
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools

March 5, 2026
Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU

December 16, 2025
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche

November 14, 2025